Marijuana reform advocates are getting concerned as rumors about the potential cancellation of a cannabis legalization vote on the House floor that’s been planned for next week continue to circulate and expand.
And they didn’t get much peace of mind when House Majority Leader Steny Hoyer (D-MD) on Tuesday seemed to signal that now might not be the right time to put the legislation to the floor. That said, a representative for his office later told Marijuana Moment that, as for now, nothing about the schedule has changed.
While leadership announced earlier this month that they intended to hold a floor vote on Marijuana Opportunity, Reinvestment and Expungement (MORE) Act during the week of September 21, there’s been some pushback from certain moderate Democrats in vulnerable reelection races who feel that advancing cannabis reform before the next round of coronavirus relief legislation would come back to bite them, even if they’re personally supportive of the proposal at a time a majority of American voters back legalizing cannabis.
Hoyer said on a press call that Democrats are “really focused on the [continuing resolution] and on the COVID-19, which are the two critical pieces of legislation that in this three-week period we have to pass,” referring to legislation to keep the government funded and avoid a shutdown at the end of this month.
“I’m a support[er] of the MORE Act, but we’ve got to get the CR and COVID-19 done, because they’re absolutely critical to the welfare of our country,” he said. “There are a lot of bills that are possible which are—which are important bills, good bills, but we’re focused on COVID-19 and the CR, because that keeps government open, and it gives assistance to millions of people who absolutely need it.”
A spokesperson for Hoyer’s office told Marijuana Moment that they didn’t have anything to add on the leader’s remarks, but that “the schedule hasn’t changed.”
Also on Tuesday, Democratic Caucus Chairman Rep. Hakeem Jeffries (D-NY) was asked about the MORE Act and said that the bill did not come up on a caucus call earlier in the day.
“We didn’t discuss the MORE Act on the call today or the timing of some of the bills that are going to be on the floor next week,” he said.
“With respect to some of the other items on the legislative agenda—particularly as it relates to next week—I’m just trying to get to tomorrow,” Jeffries added said. “That’s the approach that many of us have taken in the context of the long national nightmare that has been the Trump administration since January 20 of 2017.”
He also pushed back against criticism from the office of Senate Majority Leader Mitch McConnell (R-KY), which put out a a press release on Monday highlighting some apparent Democratic discontent with plans to hold a vote on the MORE Act.
“I think the comment about marijuana is just silliness,” he said. “They care more about the wealthy, the well-off and the well-connected.”
But it is the case that there has been some splintering over the pending scheduled vote; it’s just not clear the extent to which there’s been pushback and whether it’s enough to convince leadership to pull the bill following the public announcement of their intention to hold it this month.
“At a time when people are really struggling just to pay the bills and to get through this health crisis, [COVID relief] should be our priority,” Rep. Scott Peters (D-CA) told The Hill, adding that he’s told Democratic leadership the legislation is “probably something I would support but we should do it later on.”
Another unnamed lawmaker said that certain colleagues feel that holding a vote on the bill doesn’t make sense at this time because “it’s not something that you can get passed into law,” presumably referring to its prospects in the GOP-controlled Senate.
Rep. Earl Blumenauer (D-OR) seemed less convinced that the MORE Act stands no chance in the Senate during a virtual meeting on Tuesday that also involved Sen. Cory Booker (D-NJ). He said “I think we’re going to see not just a strong vote in the House, but I think there’s a chance that this is going to move through the Senate, with the leadership of Senator Booker.”
An aide to a senior Democrat who was also unnamed told The Hill flippantly that “prioritizing weed smokers over funding the government and providing relief to families and small businesses doesn’t make much sense to the American people.” The official added that while there are certain concerns about provisions of the bill, the ultimate issue “is the timing of this.”
House Judiciary Committee Chairman Jerrold Nadler (D-NY), sponsor of the MORE Act, acknowledged that there are discussions about delaying the vote, but told Politico that he’s feels the legislation should advance as planned.
“I’m not in favor of” a delay “because I think we can do it now,” the congressman said. He also dismissed concerns about the optics of voting on marijuana reform at this time because the issue “polls pretty well.”
But Rep. Barbara Lee (D-CA), cochair of the Congressional Cannabis Caucus, took a different stance and expressed openness to pushing the vote back if it could ultimately increase the vote count.
“We want to make sure the bill has the maximum number of votes. So the timing is not that crucial,“ she told Politico. “Whatever it takes to get unity and maximize our votes, we need to do that.”
In clarifying those comments, Lee told Marijuana Moment that legalization is “not an unpopular issue,” referring to polling data showing voter support and the growing number of states enacting reforms.
“Especially as the country reckons with its history of racial injustice, this should be seen as a prime opportunity to address a form of systemic racism,” she said. “Each day we gain more and more cosponsors, giving me no doubt that we are going to finally correct this historic injustice once and for all. We’re doing everything we can over the next week to build broad coalitions of support to ensure that happens sooner rather than later.”
Legalization advocates are pushing House leadership to move ahead with the vote next week.
“Congress has the ability and responsibility to walk and chew gum at the same time. The House can and must pass a bill that will bring justice to millions of Americans while continuing to work on other priorities,” Queen Adesuyi, policy manager for the Drug Policy Alliance, told Marijuana Moment. “Taking a vote on the MORE Act will not preclude the House from working on the CR or another COVID-19 package, which by the way, the House already voted on back in May but is now wasting away in the Senate.”
“The MORE Act is not simply a bill about the marijuana plant—it’s about addressing the unjust criminalization of a substance that has led to the economic and social devastation of millions of Americans and whole communities in the middle of a global pandemic,” she said.
Matthew Schweich, deputy director of the Marijuana Policy Project, told Marijuana Moment that the group is “confident that Congress will pass comprehensive marijuana reform legislation in the near future.”
“The precise timing of the MORE Act vote will not change the fact that 66 percent of Americans support marijuana legalization and a growing number of states are enacting marijuana reform policies,” he said.
Should the legislation be formally scheduled and head to the floor for a vote, it wouldn’t be entirely partisan, as three GOP members have already publicly said they will vote in favor of the proposal.
The latest to say as much, Rep. Don Young (R-AK), said he’s “confident” it will pass the chamber.
Rep. Matt Gaetz (R-FL), the sole GOP cosponsor on the bill, said earlier this month that he would be voting “yes” on the MORE Act, though he expressed criticism about a provision that would impose a federal excise tax on marijuana sales to be reinvested in communities most impacted by the drug war, calling them “reparations.”
Rep. Tom McClintock (R-CA) also said “I intend to vote yes on the bill” in a recent interview with Politico. “With respect to timing, I do find it ironic that the only small businesses the Democrats seem to be worried about is cannabis shops, but I would support this bill whenever it is brought to a vote,” he said.
McClintock, along with Gaetz, voted for the MORE Act when it was marked up by the Judiciary Committee last year.
This story was updated to include comment from Lee and to correct a quote misattributed to Hoyer by another outlet.
Photo courtesy of Philip Steffan.
Trump Campaign Orders Mississippi Medical Marijuana Activists To Cease Using President’s Name
President Donald Trump’s reelection campaign has issued a cease and desist order against a Mississippi medical marijuana legalization campaign, claiming “unauthorized and misleading representation” of the president’s position on the reform initiative in one of its mailers—even though he has on multiple occasions spoken favorably on camera about medical cannabis.
Michael Glassner, chief operating officer of Donald J. Trump for President Inc., sent a letter to Mississippians for Compassionate Care (MCC), demanding that they stop distributing campaign materials touting the president’s past remarks.
While the mailer and the envelope it’s being sent in don’t at any point state that Trump has specifically endorsed Initiative 65, they encourage voters to “join President Trump and 3 out of 4 Mississippi Republicans who support medical marijuana” and point out that he’s voiced “complete support for medical marijuana.”
It is indeed the case that the president has, on several occasions, stated that he’s in favor of medical cannabis reform.
For example, while he said in 2015 that Colorado has “a lot of problems going on right now” with its recreational marijuana program, medical cannabis “is another thing.”
“I think medical marijuana, 100 percent,” he said.
Beyond stating his personal support for medical cannabis, Trump has said multiple times that he personally knows people who have benefited from using it.
“I think medical should happen, right? Don’t we agree? I mean I think so,” he said at a 2015 rally in Nevada. “I know people that are very, very sick and for whatever reason, the marijuana really helps them.”
“I know people that have serious problems and they did that and it really does help them,” he said In a 2016 interview on Fox News.
But the president’s reelection campaign evidently takes issue with the state cannabis effort using his on-camera quotes.
“President Trump has never expressed support for Initiative 65, and his campaign demands that you immediately cease and desist all activities using the President’s name, image or likeness in support of the legalization of medical marijuana in Mississippi,” Glassner wrote in the October 12 letter, which was first reported by Y’all Politics.
“The President’s campaign strongly believes in and encourages your organization’s fundamental right to engage in speech on issues of public importance, but this is not about that,” he said. “You are misleadingly using the President’s name in support of your own agenda without authorization or justification.”
But MCC is defending the mailers, which also feature endorsements from multiple Republican legislators in the state.
“President Trump has clearly stated on multiple occasions that he supports medical marijuana. That is all that we’ve shared—the truth,” MCC Communications Director Jamie Grantham said in a press release. “The politicians and bureaucrats behind Mississippi Horizon clearly orchestrated this letter from the Trump campaign. It’s just the latest example of the lengths to which they will go to prevent any form of medical marijuana in Mississippi.”
“President Trump himself has said he supports medical marijuana and is letting the states decide,” she said. “Initiative 65 is the only plan on the ballot that will create an actual medical marijuana program in Mississippi.”
While Trump has made his views on medical cannabis clear—and he’s expressed support for a states’ right approach to marijuana policy—he’s also on several occasions released signing statements on spending legislation stipulating that he reserves the right to ignore a long-standing rider that prohibits the Justice Department from using its funds to interfere with state-legal medical marijuana programs.
He also proposed deleting the rider altogether in multiple annual budget proposals to Congress, though President Obama did the same thing when he was in office.
The Mississippi mailer neglected to acknowledge those nuances, however.
“For the last two years, he has signed legislation offered by Republican Senators to prevent his Department of Justice from prosecuting medical marijuana businesses in states that have legalized its use,” it states.
“The Trump campaign’s decision in this matter is a further indication that this administration is unwilling to either embrace or act upon marijuana policy reform,’ Justin Strekal, political director of NORML, told Marijuana Moment. “For four years, this administration has been silent at best and hostile at worst when it comes to marijuana policy, and there is no indication that they would change going forward if given the opportunity.”
“At the end of the day, this is just bad politics,” he said.
A Quinnipiac poll found last year that 93 percent of Americans support medical marijuana, including 86 percent of Republicans, 96 percent of Democrats and 96 percent of independents—raising questions about why the president’s reelection campaign chose to take the proactive step of distancing their candidate from such an overwhelmingly popular issue that enjoys supermajority backing across partisan lines.
Meanwhile, the Democratic presidential nominee, Joe Biden, favors legalizing medical marijuana, decriminalizing cannabis possession more broadly, expunging prior convictions, modestly rescheduling the drug under federal law and letting states set their own policies. That said, he helped craft some of the nation’s most infamously punitive anti-drug laws during his time in the Senate—a record that the Trump campaign has seized on.
“More than 81 percent of Mississippians agree with President Trump in supporting medical marijuana for people who are suffering,” Grantham said, referencing a poll released last month. “Voters see through the actions of politicians who failed to act on this issue and who are now trying to block this initiative. 65A lets politicians decide. More than 228,000 Mississippians signed petitions for Initiative 65 which lets doctors and patients decide.”
The medical cannabis reform campaign has faced a series of obstacles before and after qualifying for the state’s November ballot.
The primary complication for advocates is the fact that two competing initiatives will appear alongside each other on the ballot. After MCC qualified their measure, the legislature approved an alternative that is viewed as more restrictive. The result is a muddled ballot that requires voters to answer a two-step series of questions—and that potential confusion threatens to jeopardize the activist-led proposal.
More recently, the Mississippi State Medical Association and American Medical Association have also contributed to the opposition, circulating a sample ballot that instructs voters on how to reject Initiative 65.
Last week, Gov. Tate Reeves (R) signed legislation that amends state law to allow people to obtain marijuana-derived medications that are approved by the Food and Drug Administration. He also reiterated his opposition to broader medical cannabis reform, stating that he’s “against efforts to make marijuana mainstream.”
If the campaign’s measure passes, it would allow patients with debilitating medical issues to legally obtain marijuana after getting a doctor’s recommendation. The proposal includes 22 qualifying conditions such as cancer, chronic pain and post-traumatic stress disorder, and patients would be allowed to possess up to 2.5 ounces of marijuana per 14-day period.
In June, lawmakers introduced yet another medical cannabis alternative resolution that would’ve similarly posed a threat to the activist-driven reform initiative. But, to advocates’ relief, the legislation didn’t advance before lawmakers went home for the summer.
Read the Trump campaign’s cease and desist letter below:
New Jersey Voters Strongly Back Marijuana Legalization And Cannabis Pardons, New Poll Finds
Support for a referendum to legalize marijuana in New Jersey remains strong, according to a new poll released on Tuesday. And what’s more, voters want Gov. Phil Murphy (D) to go a step further by pardoning people with low-level cannabis convictions.
The survey, which is the fourth and final from the law firm Brach Eichler LLC this election cycle, shows that 65 percent of New Jersey voters are in favor of the reform proposal that will appear on the state’s November ballot. Just 29 percent are opposed to the policy change and six percent remain undecided.
These results are statistically consistent with the prior three polls from the firm as well as one from Fairleigh Dickinson University, which similarly found roughly two to one support for the measure. A separate survey released last week by Stockton University showed three to one support for legalizing cannabis among New Jersey voters.
As has historically been the case, Democrats are most likely to back legalization (70 percent), followed by independents (62 percent) and Republicans (52 percent).
But beyond legalizing cannabis for adult use, New Jersey voters are also strongly in favor of having the governor use his clemency powers for those previously convicted over low-level marijuana offenses. Sixty-eight percent of respondents said Murphy should grant those individuals pardons, compared to 21 percent who are against it and 11 percent who are unsure.
For the first time since the firm starting polling on cannabis issues this year, a majority of voters (51 percent) also said that prior marijuana records of all levels of convictions, rather than just simple possession, should be expunged.
“The Brach Eichler Cannabis Poll, which has consistently reported overwhelming support for legalizing cannabis, today again confirms that New Jersey voters support this long overdue change by a significant margin,” Charles Gormally, co-chair of the firm’s cannabis practice, said in a press release. “After election day it is imperative that our legislature move to create the most efficient, safe and regulated marketplace to capture the tri-state cannabis business.”
The survey, which involved interviews with 500 registered voters from October 5-13 and has a margin of error of +/- 4.4 percentage points, also asked about the policy of local control for the marijuana market. Forty-seven percent said that individual jurisdictions should be allowed to ban cannabis businesses from operating in their area, compared to 39 percent who are opposed to the proposal and 14 percent who are undecided.
“It is clear that home rule is a topic that needs to be more fully addressed,” Gormally said. “Cannabis businesses are going to need an immediate understanding of local politics and community issues before embarking on plans for certain parts of New Jersey.”
Five states have recreational or medical marijuana legalization on the ballot this election, and polling broadly indicates that the measures will be successful.
Two recent surveys of Arizona voters show growing majority support for an initiative to legalize adult-use cannabis.
Montana voters seem poised to approve a pair of marijuana legalization initiatives next month, according to a poll released last week.
In South Dakota, polling signals that voters will approve separate initiatives to allow both medical and recreational cannabis.
A survey of Mississippi voters that was released in September found that an activist-led measure to legalize medical marijuana “stands a strong chance of passage.”
Meanwhile, in New Jersey, putting legalization to voters as a referendum question was the result of the legislature’s failure to pass reform legislation last session.
Murphy, the governor, has been a vocal advocate for approving the measure.
He said during a virtual fundraiser with the pro-legalization NJ CAN 2020 earlier this month that the state “can’t fail” at enacting the policy change this round. A top lawmaker also spoke at the event and said an enabling and regulatory bill was being prepared in anticipation of a favorable vote, and that it could be voted on by the legislature as soon as the first week of November.
The governor also recently recorded a video ad that was released by the reform group, outlining why he’s embraced the policy change. Murphy said that the ongoing criminalization of cannabis in New Jersey wastes taxpayer dollars, and he emphasized that prohibition is enforced in a racially disproportionate manner.
Murphy similarly said in a recent interview that the marijuana reform proposal prioritizes social justice.
“I wish we could have gotten it done through a legislative process,” he said at the time, referencing lawmakers’ inability to advance a legalization bill last session. “We just couldn’t find the last few votes, so it’s on the referendum. I’m strongly supporting it—first and foremost for social justice reasons.”
Last month, Murphy also called on voters to support the proposal in an email blast that was circulated by the New Jersey Democratic State Committee.
“Legalization would right those wrongs while also spurring massive economic development opportunities, job creation, and new tax revenue,” the governor wrote. “Now, we have the opportunity to get this done and finally legalize adult-use marijuana here in the Garden State, and I need your help to make it happen.”
He said in July that legalizing cannabis is “an incredibly smart thing to do” both from an economic and social justice perspective.
The governor isn’t alone in his attempts to get out the vote for cannabis reform. Filmmaker Kevin Smith earlier this month urged his Twitter followers to “VOTE YES when you see State Public Question Number 1: Constitutional Amendment to Legalize Marijuana.”
NJ CAN 2020, one of two campaign committees working to pass the cannabis referendum, released a series of English- and Spanish-language video ads last week, after having published one prior ad. Meanwhile, campaign finance records compiled show that legal marijuana supporters are out-raising opponents by a ratio of nearly 130:1.
In June, the state Assembly passed a cannabis decriminalization bill that would make possession of up to two ounces a civil penalty without the threat of jail time, though it hasn’t advance in the Senate.
Photo courtesy of Philip Steffan.
Kamala Harris Touts ‘Commitment’ To Marijuana Decriminalization And Expungements Under Biden Administration
Democratic vice presidential nominee Kamala Harris (D-CA) again pledged in a new interview that decriminalizing marijuana would be an administrative priority if she and Joe Biden are elected.
Speaking to The Grio on Saturday, the senator discussed the would-be Democratic administration’s criminal justice agenda, contrasting it with that of President Donald Trump. She reiterated the cannabis reform would be among their policy goals.
“We have a commitment to decriminalizing marijuana and expunging the records of people who have been convicted of marijuana offenses,” Harris said. “When you look at the awful war on drugs and the disproportionate impact it had on black men and creating then criminal records that have deprived people of access to jobs and housing and basic benefits.”
Watch Harris discuss criminal justice and marijuana reform, starting around 12:00 into the video below:
While reform advocates have appreciated the senator’s repeated calls for cannabis reform on the campaign trail, they’ve taken issue with her tendency to refer to the drug war in the past tense—as she did here by talking about the impact the policy “had”—as though those prosecutions and enforcement disparities haven’t persisted.
In fact, recently released FBI data shows that there were 1,558,862 drug-related arrests in the U.S. last year, about a third of which were for marijuana. That amounts to a new drug bust every 20 seconds on average.
There’s also some frustration that Harris has scaled back her reform push since joining the Democratic ticket as Biden’s running mate. During her own run for the presidential nomination, she called for comprehensive marijuana legalization—a policy not supported by the former vice president despite its popularity among Democrats.
Harris, who is the lead Senate sponsor of a bill to federally deschedule marijuana, said last month that a Biden administration would not be “half-steppin’” cannabis reform or pursuing “incrementalism,” but that’s exactly how advocates would define simple decriminalization.
In any case, the senator has repeatedly discussed cannabis decriminalization on the trail. She similarly said during a vice presidential debate earlier this month that she and Biden “will decriminalize marijuana and we will expunge the records of those who have been convicted of marijuana.”
In addition to those policies, Biden backs modestly rescheduling the drug under federal law, letting states set their own policies and legalizing medical cannabis.
Photo element courtesy of California Attorney General’s Office.